These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1008 related items for PubMed ID: 31841197

  • 1. MiR-92b inhibited cells EMT by targeting Gabra3 and predicted prognosis of triple negative breast cancer patients.
    Li YY, Zheng XH, Deng AP, Wang Y, Liu J, Zhou Q, Cheng GY, Jiang Q.
    Eur Rev Med Pharmacol Sci; 2019 Dec; 23(23):10433-10442. PubMed ID: 31841197
    [Abstract] [Full Text] [Related]

  • 2. miR-365 inhibits cell invasion and migration of triple negative breast cancer through ADAM10.
    Liu F, Zhuang L, Wu R, Li D.
    J BUON; 2019 Dec; 24(5):1905-1912. PubMed ID: 31786854
    [Abstract] [Full Text] [Related]

  • 3. MiR-363 suppresses cell migration, invasion, and epithelial-mesenchymal transition of osteosarcoma by binding to NOB1.
    Zhang Y, Wang F, Wang L, Zhang Q.
    World J Surg Oncol; 2020 May 01; 18(1):83. PubMed ID: 32357945
    [Abstract] [Full Text] [Related]

  • 4. miR-122-5p promotes aggression and epithelial-mesenchymal transition in triple-negative breast cancer by suppressing charged multivesicular body protein 3 through mitogen-activated protein kinase signaling.
    Wang Z, Wang X.
    J Cell Physiol; 2020 Mar 01; 235(3):2825-2835. PubMed ID: 31541468
    [Abstract] [Full Text] [Related]

  • 5. microRNA-761 induces aggressive phenotypes in triple-negative breast cancer cells by repressing TRIM29 expression.
    Guo GC, Wang JX, Han ML, Zhang LP, Li L.
    Cell Oncol (Dordr); 2017 Apr 01; 40(2):157-166. PubMed ID: 28054302
    [Abstract] [Full Text] [Related]

  • 6. miR-124 regulates EMT based on ZEB2 target to inhibit invasion and metastasis in triple-negative breast cancer.
    Ji H, Sang M, Liu F, Ai N, Geng C.
    Pathol Res Pract; 2019 Apr 01; 215(4):697-704. PubMed ID: 30611621
    [Abstract] [Full Text] [Related]

  • 7. MiR-212-5p Suppresses the Epithelial-Mesenchymal Transition in Triple-Negative Breast Cancer by Targeting Prrx2.
    Lv ZD, Yang DX, Liu XP, Jin LY, Wang XG, Yang ZC, Liu D, Zhao JJ, Kong B, Li FN, Wang HB.
    Cell Physiol Biochem; 2017 Apr 01; 44(5):1785-1795. PubMed ID: 29216628
    [Abstract] [Full Text] [Related]

  • 8. miR-92b-3p acts as a tumor suppressor by targeting Gabra3 in pancreatic cancer.
    Long M, Zhan M, Xu S, Yang R, Chen W, Zhang S, Shi Y, He Q, Mohan M, Liu Q, Wang J.
    Mol Cancer; 2017 Oct 27; 16(1):167. PubMed ID: 29078789
    [Abstract] [Full Text] [Related]

  • 9. Regulation of cancerous progression and epithelial-mesenchymal transition by miR-34c-3p via modulation of MAP3K2 signaling in triple-negative breast cancer cells.
    Wu J, Li WZ, Huang ML, Wei HL, Wang T, Fan J, Li NL, Ling R.
    Biochem Biophys Res Commun; 2017 Jan 29; 483(1):10-16. PubMed ID: 28069384
    [Abstract] [Full Text] [Related]

  • 10. MiR-26b-5p inhibits cell proliferation and EMT by targeting MYCBP in triple-negative breast cancer.
    Ma S, Wei H, Wang C, Han J, Chen X, Li Y.
    Cell Mol Biol Lett; 2021 Dec 11; 26(1):52. PubMed ID: 34895159
    [Abstract] [Full Text] [Related]

  • 11. MicroRNA-455-3p promotes invasion and migration in triple negative breast cancer by targeting tumor suppressor EI24.
    Li Z, Meng Q, Pan A, Wu X, Cui J, Wang Y, Li L.
    Oncotarget; 2017 Mar 21; 8(12):19455-19466. PubMed ID: 28038450
    [Abstract] [Full Text] [Related]

  • 12. MiR-6838-5p suppresses cell metastasis and the EMT process in triple-negative breast cancer by targeting WNT3A to inhibit the Wnt pathway.
    Liu G, Wang P, Zhang H.
    J Gene Med; 2019 Dec 21; 21(12):e3129. PubMed ID: 31693779
    [Abstract] [Full Text] [Related]

  • 13. Dual-target MDM2/MDMX inhibitor increases the sensitization of doxorubicin and inhibits migration and invasion abilities of triple-negative breast cancer cells through activation of TAB1/TAK1/p38 MAPK pathway.
    Fan Y, Li M, Ma K, Hu Y, Jing J, Shi Y, Li E, Dong D.
    Cancer Biol Ther; 2019 Dec 21; 20(5):617-632. PubMed ID: 30462562
    [Abstract] [Full Text] [Related]

  • 14. MiR-890 inhibits proliferation and invasion and induces apoptosis in triple-negative breast cancer cells by targeting CD147.
    Wang C, Xu C, Niu R, Hu G, Gu Z, Zhuang Z.
    BMC Cancer; 2019 Jun 13; 19(1):577. PubMed ID: 31196010
    [Abstract] [Full Text] [Related]

  • 15. MiR-508-3p inhibits cell invasion and epithelial-mesenchymal transition by targeting ZEB1 in triple-negative breast cancer.
    Guo SJ, Zeng HX, Huang P, Wang S, Xie CH, Li SJ.
    Eur Rev Med Pharmacol Sci; 2018 Oct 13; 22(19):6379-6385. PubMed ID: 30338806
    [Abstract] [Full Text] [Related]

  • 16. MiR-196a promoted cell migration, invasion and the epithelial-mesenchymal transition by targeting HOXA5 in osteosarcoma.
    Wang X, Zhang L, Zhang X, Xing C, Liu R, Zhang F.
    Cancer Biomark; 2020 Oct 13; 29(2):291-298. PubMed ID: 32675397
    [Abstract] [Full Text] [Related]

  • 17. miR-3178 inhibits cell proliferation and metastasis by targeting Notch1 in triple-negative breast cancer.
    Kong P, Chen L, Yu M, Tao J, Liu J, Wang Y, Pan H, Zhou W, Wang S.
    Cell Death Dis; 2018 Oct 17; 9(11):1059. PubMed ID: 30333478
    [Abstract] [Full Text] [Related]

  • 18. UBE2C, Directly Targeted by miR-548e-5p, Increases the Cellular Growth and Invasive Abilities of Cancer Cells Interacting with the EMT Marker Protein Zinc Finger E-box Binding Homeobox 1/2 in NSCLC.
    Jin D, Guo J, Wu Y, Du J, Wang X, An J, Hu B, Kong L, Di W, Wang W.
    Theranostics; 2019 Oct 17; 9(7):2036-2055. PubMed ID: 31037155
    [Abstract] [Full Text] [Related]

  • 19. MicroRNA-200c Inhibits the Metastasis of Triple-Negative Breast Cancer by Targeting ZEB2, an Epithelial-Mesenchymal Transition Regulator.
    Chen H, Li Z, Zhang L, Zhang L, Zhang Y, Wang Y, Xu M, Zhong Q.
    Ann Clin Lab Sci; 2020 Jul 17; 50(4):519-527. PubMed ID: 32826250
    [Abstract] [Full Text] [Related]

  • 20. MicroRNA-498 promotes proliferation and migration by targeting the tumor suppressor PTEN in breast cancer cells.
    Chai C, Wu H, Wang B, Eisenstat DD, Leng RP.
    Carcinogenesis; 2018 Sep 21; 39(9):1185-1196. PubMed ID: 29985991
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 51.